All TreatmentsFertility
Cartridge Only
FDA-approved
LIMITED AVAILABILITY
Temporarily Out of Stock

Follistim® AQ 600 U/0.72 mL Cartridge

Manufacturer
Manufacturer name
Strength
600 IU
Placeholder Dosage note
$22.99
Package 30
Retail price:
$119.00
$18.00
When you buy 32 or more
Retail price:
$119.00
Prescription Required. 
Join the club to consult with a provider and start treatment.

Frequently Asked Questions.

This section covers the key questions around product details.

Product Details.

Follistim® AQ Cartridge is a prescription fertility medication. It is used in women to stimulate the ovaries to produce multiple eggs as part of assisted reproductive technologies such as IVF. In men, it is indicated to treat infertility due to primary or secondary hypogonadotropic hypogonadism by stimulating sperm production. Available by prescription only.

What to Expect.

Each prefilled cartridge is for use only with the Follistim Pen®, a reusable injection device designad for accurate, convenient subcutaneous administration. Dosage and duration are individualized and should be determined by a healthcare provider experienced in fertility treatment. ‍

Safety Information.

CONTRAINDICATIONS: FOLLISTIM AQ Cartridge is contraindicated in women who exhibit any of the following: prior hypersensitivity to recombinant human follicle-stimulating hormone (hFSH) products; high levels of FSH indicating primary gonadal failure; presence of uncontrolled non-gonadal endocrinopathies (eg, thyroid, adrenal, or pituitary disorders); hypersensitivity reactions to streptomycin or neomycin (FOLLISTIM AQ may contain traces of these antibiotics.); tumors of the ovary, breast, uterus, hypothalamus, or pituitary gland; pregnancy; heavy or irregular vaginal bleeding of undetermined origin; or ovarian cysts or enlargement not due to polycystic ovary syndrome (PCOS). WARNINGS AND PRECAUTIONS FOLLISTIM AQ Cartridge should be prescribed only by physicians who are experienced in infertility treatment. FOLLISTIM AQ Cartridge contains a potent gonadotropic substance capable of causing ovarian hyperstimulation syndrome (OHSS) with or without pulmonary or vascular complications and multiple births. Gonadotropin therapy requires the availability of appropriate monitoring facilities. [Click here] (https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48489027-e52b-4b10-ae74-4ba03839150c&audience=consumer) for full Prescribing Information and Patient Information. ‍

Start your Hormonal Health Journey Today.